US

Jay Hang Chung

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jay Hang Chung. Retrieved from https://idiyas.com/inventor/jay-hang-chung-gz3l9swa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Jay Hang Chung: Innovator in Inflammatory Disease Treatment

Introduction

Jay Hang Chung is an accomplished inventor based in the United States. He has made significant contributions to the field of medical research, particularly in the area of inflammatory diseases. His work focuses on developing innovative solutions to improve patient outcomes.

Latest Patents

Jay Hang Chung holds a patent for "Molecules Inhibiting Intercellular Adhesion." This patent discloses molecules that inhibit intercellular adhesion during inflammation and outlines their potential use in treating inflammatory diseases. Although he currently has 0 patents, his research is pivotal in advancing therapeutic options.

Career Highlights

Chung is associated with Isu Abxis Co., Ltd., a company dedicated to biopharmaceutical innovations. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Myung Kyung Kim. Together, they work on projects aimed at enhancing the understanding and treatment of inflammatory conditions.

Conclusion

Jay Hang Chung is a dedicated inventor whose work in developing molecules for treating inflammatory diseases showcases his commitment to medical innovation. His contributions, although currently limited in patent count, hold promise for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…